Logan Brenzel
Logan Brenzel has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Coile
JSI Research & Training Institute, Inc., Arlington, VA, 22202, USA
2 shared publications Annette Zou
Global ChangeLabs, Portola Valley, CA, 94028, USA
2 shared publicationsBanny Banerjee
Global ChangeLabs, Portola Valley, CA, 94028, USA
2 shared publications- Barbara Knittel
JSI Research & Training Institute, Inc., Arlington, VA, 22202, USA
2 shared publications - Bryan Patenaude
Affiliation Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America
2 shared publications Cecilia Abimbola Williams
Independent Consultant, Abuja, Nigeria
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by F1000 Research Ltd in VeriXiv
Unveiling the Cost Drivers of Reaching Zero-Dose Children: Insights from Health Facility and Intervention-Specific Costs in Kano State, Nigeria
- 16 September 2026
- Published by F1000 Research Ltd in VeriXiv
Open AccessUnveiling the Cost Drivers of Reaching Zero-Dose Children: Insights from Health Facility and Intervention-Specific Costs in Kano State, Nigeria
- Open Access
- 12 August 2026
- Published by F1000 Research Ltd in VeriXiv
Comparative Implementation Costs of Vaccination Coverage Survey Methodologies in the Democratic Republic of the Congo and the Central African Republic
- 12 August 2026
- Published by F1000 Research Ltd in VeriXiv
Open AccessComparative Implementation Costs of Vaccination Coverage Survey Methodologies in the Democratic Republic of the Congo and the Central African Republic
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Applying a human-centered design approach to developing interventions to reduce the number of zero-dose children in Tshopo Province, Democratic Republic of the Congo: A costing analysis
The Democratic Republic of the Congo (DRC) is among the countries with the highest number of zero-dose and under-immunized children in the world. Tshopo Province, located in the North-Central area of the country, is particularly impacted, with alarmingly low immunization rates and a proportion of zero-dose children higher than 60%. Innovative and targeted interventions are required to reach children missed by the immunization program. In collaboration with the DRC Ministry of Health, PATH implemented a human-centered design (HCD) project to co-create and test solutions that could help the community address the issue in four targeted health areas.As part of the project, we conducted a study to assess the incremental financial, opportunity, and economic costs of implementing the HCD approach and derived prototype interventions. The aim was to inform decision-makers and technical and financial partners about the economic viability of the HCD approach and its potential for scale-up and to provide a basis for comparison with other strategies to improve immunization coverage. Using a microcosting, ingredients-based approach, we documented and valued all resources used during the project and reported cost per pre-defined activities and cost categories.Among the interventions implemented, the most cost-efficient was the involvement of private health facilities in immunization activities. This intervention led to a cost per child vaccinated with the first dose of pentavalent vaccine of $5 (financial) and $10 (economic) when excluding learning-by-doing activities. Main cost drivers for this intervention include human resources, workshop and events organization, and transportation and logistics. Cost per outcome ratios reported for other interventions remained within the range of published estimates for similar studies. The costs of the interventions are expected to decrease following their initial implementation. Given these results, HCD-developed approaches likely represent an affordable way for governments to identify appropriate and affordable interventions to improve childhood immunization rates.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessApplying a human-centered design approach to developing interventions to reduce the number of zero-dose children in Tshopo Province, Democratic Republic of the Congo: A costing analysis
The Democratic Republic of the Congo (DRC) is among the countries with the highest number of zero-dose and under-immunized children in the world. Tshopo Province, located in the North-Central area of the country, is particularly impacted, with alarmingly low immunization rates and a proportion of zero-dose children higher than 60%. Innovative and targeted interventions are required to reach children missed by the immunization program. In collaboration with the DRC Ministry of Health, PATH implemented a human-centered design (HCD) project to co-create and test solutions that could help the community address the issue in four targeted health areas.As part of the project, we conducted a study to assess the incremental financial, opportunity, and economic costs of implementing the HCD approach and derived prototype interventions. The aim was to inform decision-makers and technical and financial partners about the economic viability of the HCD approach and its potential for scale-up and to provide a basis for comparison with other strategies to improve immunization coverage. Using a microcosting, ingredients-based approach, we documented and valued all resources used during the project and reported cost per pre-defined activities and cost categories.Among the interventions implemented, the most cost-efficient was the involvement of private health facilities in immunization activities. This intervention led to a cost per child vaccinated with the first dose of pentavalent vaccine of $5 (financial) and $10 (economic) when excluding learning-by-doing activities. Main cost drivers for this intervention include human resources, workshop and events organization, and transportation and logistics. Cost per outcome ratios reported for other interventions remained within the range of published estimates for similar studies. The costs of the interventions are expected to decrease following their initial implementation. Given these results, HCD-developed approaches likely represent an affordable way for governments to identify appropriate and affordable interventions to improve childhood immunization rates.
- Open Access
- 20 July 2026
- Published by F1000 Research Ltd in VeriXiv
Comparison of the cost and precision of six coverage methods to estimate zero-dose vaccination prevalence in Kano State, Nigeria
- 20 July 2026
- Published by F1000 Research Ltd in VeriXiv
Open AccessComparison of the cost and precision of six coverage methods to estimate zero-dose vaccination prevalence in Kano State, Nigeria
- Open Access
- 2 July 2026
- Published by F1000 Research Ltd in VeriXiv
Cost of immunization coverage surveys in low- and middle-income countries
- 2 July 2026
- Published by F1000 Research Ltd in VeriXiv
Open AccessCost of immunization coverage surveys in low- and middle-income countries
- Open Access
Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysis
Background: Reliable estimates of immunization delivery costs are essential for planning, budgeting, and economic evaluation. Despite recent empirical studies, many low- and middle-income countries (LMICs) lack up-to-date cost estimates, particularly for adolescent and campaign vaccination. This study generated standardized country-level delivery cost estimates across vaccination modalities in LMICs. Methods: Using data from empirical costing studies in the 2024 update of the Immunization Delivery Cost Catalogue, we fitted Bayesian meta-regression models to estimate per-dose delivery costs, not including vaccine and injection supplies costs, for routine childhood vaccination, routine adolescent vaccination (using human papillomavirus vaccination as a proxy), and mass campaigns. Models incorporated country-level covariates (gross domestic product per capita, population size, diphtheria-tetanus-pertussis third-dose coverage, urbanization, population density, and under-five mortality) and study-level characteristics (cost category and costing perspective). Fitted models were used to generate country-specific and population-weighted mean economic and financial costs per dose in 2024 US dollars. Results: The analysis included 141 observations for routine childhood, 49 for adolescent, and 104 for campaign vaccination. The population-weighted mean full economic cost per dose across LMICs was $4.27 (95% prediction interval: $1.95–11.58) for routine childhood vaccination, $20.56 ($8.56–57.83) for adolescent vaccination, and $14.71 ($4.90–86.98) for campaigns. Corresponding estimates for incremental economic costs per dose were $16.64 ($7.90–38.22), $20.43 ($8.27–47.78), and $3.53 ($1.70–8.56). Substantial heterogeneity was observed across countries, delivery modalities, and cost perspectives. Conclusions: Leveraging an expanded evidence-base and Bayesian meta-regression, this study provides updated delivery cost estimates across vaccination modalities for 136 LMICs. These estimates offer a practical resource for analyses where empirical cost data are unavailable. Key points: This study provides updated estimates of how much it costs to deliver vaccines across low- and middle-income countries, showing that costs vary widely depending on how vaccines are delivered and the context of each country. On average, delivering vaccines to adolescents (facility-based, school-based, and outreach) is substantially more expensive than routine childhood vaccination, while campaign delivery costs fall in between, reflecting differences in logistics and delivery strategies. These results offer practical, comparable cost benchmarks that policymakers and researchers can use to plan immunization programs and make informed decisions when country-specific data are not available.
Open AccessStandardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysis
Background: Reliable estimates of immunization delivery costs are essential for planning, budgeting, and economic evaluation. Despite recent empirical studies, many low- and middle-income countries (LMICs) lack up-to-date cost estimates, particularly for adolescent and campaign vaccination. This study generated standardized country-level delivery cost estimates across vaccination modalities in LMICs. Methods: Using data from empirical costing studies in the 2024 update of the Immunization Delivery Cost Catalogue, we fitted Bayesian meta-regression models to estimate per-dose delivery costs, not including vaccine and injection supplies costs, for routine childhood vaccination, routine adolescent vaccination (using human papillomavirus vaccination as a proxy), and mass campaigns. Models incorporated country-level covariates (gross domestic product per capita, population size, diphtheria-tetanus-pertussis third-dose coverage, urbanization, population density, and under-five mortality) and study-level characteristics (cost category and costing perspective). Fitted models were used to generate country-specific and population-weighted mean economic and financial costs per dose in 2024 US dollars. Results: The analysis included 141 observations for routine childhood, 49 for adolescent, and 104 for campaign vaccination. The population-weighted mean full economic cost per dose across LMICs was $4.27 (95% prediction interval: $1.95–11.58) for routine childhood vaccination, $20.56 ($8.56–57.83) for adolescent vaccination, and $14.71 ($4.90–86.98) for campaigns. Corresponding estimates for incremental economic costs per dose were $16.64 ($7.90–38.22), $20.43 ($8.27–47.78), and $3.53 ($1.70–8.56). Substantial heterogeneity was observed across countries, delivery modalities, and cost perspectives. Conclusions: Leveraging an expanded evidence-base and Bayesian meta-regression, this study provides updated delivery cost estimates across vaccination modalities for 136 LMICs. These estimates offer a practical resource for analyses where empirical cost data are unavailable. Key points: This study provides updated estimates of how much it costs to deliver vaccines across low- and middle-income countries, showing that costs vary widely depending on how vaccines are delivered and the context of each country. On average, delivering vaccines to adolescents (facility-based, school-based, and outreach) is substantially more expensive than routine childhood vaccination, while campaign delivery costs fall in between, reflecting differences in logistics and delivery strategies. These results offer practical, comparable cost benchmarks that policymakers and researchers can use to plan immunization programs and make informed decisions when country-specific data are not available.
- Open Access
- 28 February 2023
- Published by Oxford University Press (OUP)
Copyright Page
Great Clarendon Street, Oxford, OX2 6DP,United KingdomOxford University Press is a department of the University of Oxford.It furthers the University’s objective
- 28 February 2023
- Published by Oxford University Press (OUP)
Open AccessCopyright Page
Great Clarendon Street, Oxford, OX2 6DP,United KingdomOxford University Press is a department of the University of Oxford.It furthers the University’s objective
- Open Access
- 18 January 2023
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 116
Critical barriers to sustainable capacity strengthening in global health: a systems perspective on development assistance
Background: Development assistance for health (DAH) is an important mechanism for funding and technical support to low-income countries. Despite increased DAH spending, intractable health challenges remain. Recent decades have seen numerous efforts to reform DAH models, yet pernicious challenges persist amidst structural complexities and a growing number of actors. Systems-based approaches are promising for understanding these types of complex adaptive systems. This paper presents a systems-based understanding of DAH, including barriers to achieving sustainable and effective country-driven models for technical assistance and capacity strengthening to achieve better outcomes Methods: We applied an innovative systems-based approach to explore and map how donor structures, processes, and norms pose challenges to improving development assistance models. The system mapping was carried out through an iterative co-creation process including a series of discussions and workshops with diverse stakeholders across 13 countries. Results: Nine systemic challenges emerged: 1) reliance on external implementing partners undermines national capacity; 2) prioritizing global initiatives undercuts local programming; 3) inadequate contextualization hampers program sustainability; 4) decision-maker blind spots inhibit capacity to address inequities; 5) power asymmetries undermine local decision making; 6) donor funding structures pose limitations downstream; 7) program fragmentation impedes long-term country planning; 8) reliance on incomplete data perpetuates inequities; and 9) overemphasis on donor-prioritized data perpetuates fragmentation. Conclusions: These interconnected challenges illustrate interdependencies and feedback loops manifesting throughout the system. A particular driving force across these system barriers is the influence of power asymmetries between actors. The articulation of these challenges can help stakeholders overcome biases about the efficacy of the system and their role in perpetuating the issues. These findings indicate that change is needed not only in how we design and implement global health programs, but in how system actors interact. This requires co-creating solutions that shift the structures, norms, and mindsets governing DAH models.
- 18 January 2023
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 116
Open AccessCritical barriers to sustainable capacity strengthening in global health: a systems perspective on development assistance
Background: Development assistance for health (DAH) is an important mechanism for funding and technical support to low-income countries. Despite increased DAH spending, intractable health challenges remain. Recent decades have seen numerous efforts to reform DAH models, yet pernicious challenges persist amidst structural complexities and a growing number of actors. Systems-based approaches are promising for understanding these types of complex adaptive systems. This paper presents a systems-based understanding of DAH, including barriers to achieving sustainable and effective country-driven models for technical assistance and capacity strengthening to achieve better outcomes Methods: We applied an innovative systems-based approach to explore and map how donor structures, processes, and norms pose challenges to improving development assistance models. The system mapping was carried out through an iterative co-creation process including a series of discussions and workshops with diverse stakeholders across 13 countries. Results: Nine systemic challenges emerged: 1) reliance on external implementing partners undermines national capacity; 2) prioritizing global initiatives undercuts local programming; 3) inadequate contextualization hampers program sustainability; 4) decision-maker blind spots inhibit capacity to address inequities; 5) power asymmetries undermine local decision making; 6) donor funding structures pose limitations downstream; 7) program fragmentation impedes long-term country planning; 8) reliance on incomplete data perpetuates inequities; and 9) overemphasis on donor-prioritized data perpetuates fragmentation. Conclusions: These interconnected challenges illustrate interdependencies and feedback loops manifesting throughout the system. A particular driving force across these system barriers is the influence of power asymmetries between actors. The articulation of these challenges can help stakeholders overcome biases about the efficacy of the system and their role in perpetuating the issues. These findings indicate that change is needed not only in how we design and implement global health programs, but in how system actors interact. This requires co-creating solutions that shift the structures, norms, and mindsets governing DAH models.
- Open Access
- 24 August 2022
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 116
Critical barriers to sustainable capacity strengthening in global health: a systems perspective on development assistance
Background: Development assistance for health (DAH) is an important mechanism for funding and technical support to low-income countries. Despite increased DAH spending, intractable health challenges remain. Recent decades have seen numerous efforts to reform DAH models, yet pernicious challenges persist amidst structural complexities and a growing number of actors. Systems-based approaches are promising for understanding these types of complex adaptive systems. This paper presents a systems-based understanding of DAH, including barriers to achieving sustainable and effective country-driven models for technical assistance and capacity strengthening to achieve better outcomes Methods: We applied an innovative systems-based approach to explore and map how donor structures, processes, and norms pose challenges to improving development assistance models. The system mapping was carried out through an iterative co-creation process including a series of discussions and workshops with diverse stakeholders across 13 countries. Results: Nine systemic challenges emerged: 1) reliance on external implementing partners undermines national capacity; 2) prioritizing global initiatives undercuts local programming; 3) inadequate contextualization hampers program sustainability; 4) decision-maker blind spots inhibit capacity to address inequities; 5) power asymmetries undermine local decision making; 6) donor funding structures pose limitations downstream; 7) program fragmentation impedes long-term country planning; 8) reliance on incomplete data perpetuates inequities; and 9) overemphasis on donor-prioritized data perpetuates fragmentation. Conclusions: These interconnected challenges illustrate interdependencies and feedback loops manifesting throughout the system. A particular driving force across these system barriers is the influence of power asymmetries between actors. The articulation of these challenges can help stakeholders overcome biases about the efficacy of the system and their role in perpetuating the issues. These findings indicate that change is needed not only in how we design and implement global health programs, but in how system actors interact. This requires co-creating solutions that shift the structures, norms, and mindsets governing DAH models.
- 24 August 2022
- Published by F1000 Research Ltd in Gates Open Research
- Vol. 6, 116
Open AccessCritical barriers to sustainable capacity strengthening in global health: a systems perspective on development assistance
Background: Development assistance for health (DAH) is an important mechanism for funding and technical support to low-income countries. Despite increased DAH spending, intractable health challenges remain. Recent decades have seen numerous efforts to reform DAH models, yet pernicious challenges persist amidst structural complexities and a growing number of actors. Systems-based approaches are promising for understanding these types of complex adaptive systems. This paper presents a systems-based understanding of DAH, including barriers to achieving sustainable and effective country-driven models for technical assistance and capacity strengthening to achieve better outcomes Methods: We applied an innovative systems-based approach to explore and map how donor structures, processes, and norms pose challenges to improving development assistance models. The system mapping was carried out through an iterative co-creation process including a series of discussions and workshops with diverse stakeholders across 13 countries. Results: Nine systemic challenges emerged: 1) reliance on external implementing partners undermines national capacity; 2) prioritizing global initiatives undercuts local programming; 3) inadequate contextualization hampers program sustainability; 4) decision-maker blind spots inhibit capacity to address inequities; 5) power asymmetries undermine local decision making; 6) donor funding structures pose limitations downstream; 7) program fragmentation impedes long-term country planning; 8) reliance on incomplete data perpetuates inequities; and 9) overemphasis on donor-prioritized data perpetuates fragmentation. Conclusions: These interconnected challenges illustrate interdependencies and feedback loops manifesting throughout the system. A particular driving force across these system barriers is the influence of power asymmetries between actors. The articulation of these challenges can help stakeholders overcome biases about the efficacy of the system and their role in perpetuating the issues. These findings indicate that change is needed not only in how we design and implement global health programs, but in how system actors interact. This requires co-creating solutions that shift the structures, norms, and mindsets governing DAH models.
- Open Access
- 4 August 2020
- Published by Springer Nature in PharmacoEconomics
- Vol. 38 (10) , 1071-1094
Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies
Background: Cost-of-illness data from empirical studies provide insights into the use of healthcare resources including both expenditures and the opportunity cost related to receiving treatment. Objective: The objective of this systematic review was to gather cost data and relevant parameters for hepatitis B, pneumonia, meningitis, encephalitis caused by Japanese encephalitis, rubella, yellow fever, measles, influenza, and acute gastroenteritis in children in low- and middle-income countries. Data Sources: Peer-reviewed studies published in public health, medical, and economic journals indexed in PubMed (MEDLINE), Embase, and EconLit. Study Eligibility Criteria, Participants, and Interventions: Studies must (1) be peer reviewed, (2) be published in 2000–2016, (3) provide cost data for one of the nine diseases in children aged under 5 years in low- and middle-income countries, and (4) generated from primary data collection. Limitations: We cannot exclude missing a few articles in our review. Measures were taken to reduce this risk. Several articles published since 2016 are omitted from the systematic review results, these articles are included in the discussion. Conclusions and Implications of Key Findings: The review yielded 37 articles and 267 sets of cost estimates. We found no cost-of-illness studies with cost estimates for hepatitis B, measles, rubella, or yellow fever from primary data. Most estimates were from countries in Gavi preparatory (28%) and accelerated (28%) transition, followed by those who are initiating self-financing (22%) and those not eligible for Gavi support (19%). Thirteen articles compared household expenses to manage illnesses with income and two articles with other household expenses, such as food, clothing, and rent. An episode of illness represented 1–75% of the household’s monthly income or 10–83% of its monthly expenses. Articles that presented both household and government perspectives showed that most often governments incurred greater costs than households, including non-medical and indirect costs, across countries of all income statuses, with a few notable exceptions. Although limited for low- and middle-income country settings, cost estimates generated from primary data collection provided a ‘real-world’ estimate of the economic burden of vaccine-preventable diseases. Additional information on whether common situations preventing the application of official clinical guidelines (such as medication stock-outs) occurred would help reveal deficiencies in the health system. Improving the availability of cost-of-illness evidence can inform the public policy agenda about healthcare priorities and can help to operationalize the healthcare budget in local health systems to respond adequately to the burden of illness in the community.
- 4 August 2020
- Published by Springer Nature in PharmacoEconomics
- Vol. 38 (10) , 1071-1094
Open AccessCost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies
Background: Cost-of-illness data from empirical studies provide insights into the use of healthcare resources including both expenditures and the opportunity cost related to receiving treatment. Objective: The objective of this systematic review was to gather cost data and relevant parameters for hepatitis B, pneumonia, meningitis, encephalitis caused by Japanese encephalitis, rubella, yellow fever, measles, influenza, and acute gastroenteritis in children in low- and middle-income countries. Data Sources: Peer-reviewed studies published in public health, medical, and economic journals indexed in PubMed (MEDLINE), Embase, and EconLit. Study Eligibility Criteria, Participants, and Interventions: Studies must (1) be peer reviewed, (2) be published in 2000–2016, (3) provide cost data for one of the nine diseases in children aged under 5 years in low- and middle-income countries, and (4) generated from primary data collection. Limitations: We cannot exclude missing a few articles in our review. Measures were taken to reduce this risk. Several articles published since 2016 are omitted from the systematic review results, these articles are included in the discussion. Conclusions and Implications of Key Findings: The review yielded 37 articles and 267 sets of cost estimates. We found no cost-of-illness studies with cost estimates for hepatitis B, measles, rubella, or yellow fever from primary data. Most estimates were from countries in Gavi preparatory (28%) and accelerated (28%) transition, followed by those who are initiating self-financing (22%) and those not eligible for Gavi support (19%). Thirteen articles compared household expenses to manage illnesses with income and two articles with other household expenses, such as food, clothing, and rent. An episode of illness represented 1–75% of the household’s monthly income or 10–83% of its monthly expenses. Articles that presented both household and government perspectives showed that most often governments incurred greater costs than households, including non-medical and indirect costs, across countries of all income statuses, with a few notable exceptions. Although limited for low- and middle-income country settings, cost estimates generated from primary data collection provided a ‘real-world’ estimate of the economic burden of vaccine-preventable diseases. Additional information on whether common situations preventing the application of official clinical guidelines (such as medication stock-outs) occurred would help reveal deficiencies in the health system. Improving the availability of cost-of-illness evidence can inform the public policy agenda about healthcare priorities and can help to operationalize the healthcare budget in local health systems to respond adequately to the burden of illness in the community.